Glenmark Pharmaceuticals receives ANDA approval for Atomoxetine capsule
Updated: May 31, 2017 01:32 PM IST
The Glenmark Pharmaceuticals has been granted permission by the United States Food & Drug Administration (U.S. FDA) for Atomoxetine capsules.
The Glenmark Pharmaceuticals has been granted permission by the United States Food & Drug Administration (U.S. FDA) for Atomoxetine capsules.
